Skip to main content
. 2020 Dec 20;23(12):1080–1086. [Article in Chinese] doi: 10.3779/j.issn.1009-3419.2020.103.18

表 1.

肺腺癌患者EGFR基因检测情况

EGFR mutation status in lung adenocarcinoma patients

Item etDNA Total cell DNA ETC-DNA
EGFR: epidermal growth factor receptor; etDNA: tumor derived DNA from pleural effusion supernatant; ETC-DNA: DNA from tumor cells in pleural effusion.
EGFR mutation rate (n=10) 70.00% 50.00% 70.00%
EGFRmutation abundance
[median, (interquel range)] (n=7)
16.05% (4.78%-43.06%) 1.09% (0.00%-2.39%) 33.02% (18.50%-76.70%)